Texas invests $50M in psychedelic drug research to treat addiction
Medical Xpress
JUNE 16, 2025
Share Tweet Share Email Home Psychology & Psychiatry Home Addiction June 16, 2025 The GIST Texas invests $50M in psychedelic drug research to treat addiction by I. The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Food and Drug Administration (FDA).
Let's personalize your content